Investors searching for “Blue Mountain Resources stock” in late 2025 often hit a confusing wall: the company name still appears around the web, but there is no active stock trading under that label today.
Here’s a clear, up-to-date look at what happened to Blue Mountain Resources, how it turned into Patient Access Solutions Inc. (ticker: PASO), what the latest available data show as of November 23, 2025, and why there is no fresh company news today.
1. Is “Blue Mountain Resources” Still a Public Stock in 2025?
Short answer: no, not under that name.
Blue Mountain Resources has existed in several different forms:
- Blue Mountain Resources, Inc. (Nevada) – a small mining-focused company that later pivoted into healthcare IT and changed its name to Patient Access Solutions Inc. (PASO) on June 2, 2008.
- Blue Mountain Resources Ltd. (Canada) – an oil & gas company that was involved in corporate transactions and is now listed in Canadian corporate records as a predecessor/defunct entity or subject to name changes (e.g., to Blue Mountain Energy Ltd.).
- Blue Mountain Resources Pte. Ltd. (Singapore) – a private holding company, not a listed stock.
For stock-market purposes in the U.S., the relevant successor today is Patient Access Solutions Inc. (PASO), quoted on the OTC market. Multiple profiles confirm that PASO was formerly known as Blue Mountain Resources Inc. and that the legacy entity is now classified as “out of business” under the old name. PitchBook+1
So, if you’re trying to look up “Blue Mountain Resources stock price today”, you’re effectively looking for PASO.
2. How Blue Mountain Resources Became Patient Access Solutions (PASO)
According to company filings and OTC disclosures:
- The company incorporated as Blue Mountain Resources, Inc. in 2006.
- It originally pursued mineral exploration, then shifted into healthcare technology, rebranding as Patient Access Solutions Inc. in June 2008.
- Over time, it marketed the PASHealth Web Portal System, a healthcare IT platform for eligibility, referrals, e-prescribing, and related services.
By 2025, reference databases and market intelligence platforms clearly list Blue Mountain Resources Inc. as a former name and indicate the entity is no longer active under that label; PASO is the surviving ticker.
3. PASO (Formerly Blue Mountain Resources) Stock Snapshot as of Late 2025
Although markets in the U.S. are closed today (Sunday, November 23, 2025), we can look at the latest available trading data for Patient Access Solutions Inc. (PASO), the successor to Blue Mountain Resources:
- Exchange: OTC Markets (Pink/OTC tier)
- Recent indicative price: multiple data providers show PASO trading at about USD 0.0001 per share in 2025, with essentially no price movement and a very tight 52-week range at the same level.
- Market cap: extremely small, on the order of only a few thousand US dollars, indicating a micro-micro-cap or effectively dormant listing.
Historical price data on Yahoo Finance and other trackers show repeated daily closes at 0.0001 USD throughout 2024–2025, underlining just how illiquid and stagnant the stock has become.
Important: Prices in this range typically indicate a high-risk penny stock with minimal active trading, large bid–ask spreads when orders do show up, and a significant risk of losing your entire investment.
4. News Check for November 23, 2025: Any Fresh Blue Mountain / PASO Headlines?
You asked specifically for “all current news from 23.11.2025.”
After checking major financial and corporate news sources (Reuters, Nasdaq, OTC Markets, major press-release wires and market-data sites) for November 23, 2025, there are:
No new press releases, SEC filings, or company-specific news items dated November 23, 2025 for either “Blue Mountain Resources” or Patient Access Solutions Inc. (PASO).
What we do see is:
- No recent PASO-specific press releases on mainstream financial portals in 2024–2025; the last widely cited press releases about PASO’s operations date back to mid-2021, when the company announced an acquisition of telamentalhealth.com and the opening of a managed medical center in New York.
- Historical SEC enforcement action (2022), where regulators charged PASO and executives with making misleading merger and dividend claims in company communications.
In other words: today (23 November 2025) is a “no-news” day for the stock. Any price or volume moves, if they occur at all, are happening without fresh, publicly disclosed fundamental catalysts.
5. Why “Blue Mountain Resources” Keeps Showing Up Online
A quick search for “Blue Mountain Resources” in 2025 returns a mix of corporate records, historical references, and unrelated private companies, including:
- A Singapore holding company named Blue Mountain Resources Pte. Ltd., registered as a private company limited by shares (not publicly traded).
- A U.S. trucking/transportation company, Blue Mountain Resources LLC, registered with the U.S. Federal Motor Carrier Safety Administration—again, a private business, not a stock.
- Historical references in energy and mining transactions, where Blue Mountain Resources Ltd. appears as an acquired or renamed entity, or as an operator in older oil & gas projects.
None of these are investable tickers today. They just reuse the same name, which explains why investors often get confused when they search for “Blue Mountain Resources stock” and don’t see a clean, active listing.
6. Key Risks for Anyone Considering PASO (Ex-Blue Mountain Resources)
Although this article is not investment advice, a few risk points are worth flagging for readers:
- Extreme Illiquidity
- With a quoted price around $0.0001 and tiny market cap, PASO behaves more like a dormant shell or distressed microcap than a functioning, growth-stage business.
- Regulatory History
- The SEC’s 2022 enforcement action against PASO and certain executives, linked to allegedly false merger and dividend statements, is a serious red flag about the company’s disclosure history.
- Lack of Fresh Fundamental Information
- Publicly accessible financials for PASO largely stop well over a decade ago, and recent audited financial statements or detailed operational updates are not readily available through mainstream channels.
- Penny-Stock and Pink-Sheet Environment
- OTC stocks at this level are especially vulnerable to promotional campaigns, message-board hype, and sharp swings even on tiny trading volumes.
For anyone considering exposure, it’s crucial to recognize that there is no active “Blue Mountain Resources” stock any more—only PASO, which is speculative in the extreme.
7. What to Watch Going Forward
If you are tracking this story for investment or journalistic reasons, here’s what might actually matter after November 23, 2025:
- Regulatory Filings & Legal Updates
- Any new SEC filings, enforcement updates, or legal developments involving PASO or its management would be material, given the 2022 case.
- Corporate Disclosures on OTC Markets or Company Channels
- A real, verifiable press release with third-party confirmation (e.g., a contract, acquisition, audited results) would be more meaningful than any message-board rumor.
- Corporate Actions (Reverse Splits, Name Changes, Mergers)
- For microcaps at this stage, events like a reverse split, custodianship changes, or attempts to repurpose the shell sometimes occur. Those would typically show up via OTC Markets updates or state/corporate registries.
- Evidence of Genuine Operating Activity
- New product launches, genuine customer wins, credible partnerships or independently verifiable clinics and services using PASO’s technology would all matter more than nominal price ticks at $0.0001.
8. Takeaway for November 23, 2025
- There is no actively traded stock called “Blue Mountain Resources” today.
- The successor ticker is PASO (Patient Access Solutions Inc.), trading on the OTC market at roughly $0.0001 per share, with negligible liquidity.
- No new company news, filings, or press releases are dated November 23, 2025 for Blue Mountain Resources or PASO.
- For investors, this story is less about a “hidden gem” and more about understanding a legacy name, a distressed microcap, and the risks around thinly traded OTC equities.
Disclaimer
This article is for information and news purposes only and does not constitute investment advice, a solicitation, or a recommendation to buy or sell any security. Always perform your own due diligence and, where appropriate, consult a licensed financial professional before making investment decisions.
